Abstract:Alzheimers disease leads to progressive neurodegeneration and dementia. Alzheimers disease primarily affects older adults with neuropathological changes including amyloid beta deposition, neuroinflammation, and neurodegeneration. We have previously demonstrated that systemic treatment with combined stem cell factor, SCF, and granulocyte colony stimulating factor, GCSF, reduces amyloid beta load, increases amyloid beta uptake by activated microglia and macrophages, reduces neuroinflammation, and restores dendrites and synapses in the brains of aged APP–PS1 mice. However, the mechanisms underlying SCF–GCSF–enhanced brain repair in aged APP–PS1 mice remain unclear. This study used a transcriptomic approach to identify potential mechanisms by which SCF–GCSF treatment modulates microglia and peripheral myeloid cells to mitigate Alzheimers disease pathology in the aged brain. After injections of SCF–GCSF for 5 consecutive days, single cell RNA sequencing was performed on CD11b positive cells isolated from the brains of 28–month–old APP–PS1 mice. The vast majority of cell clusters aligned with transcriptional profiles of microglia in various activation states. However, SCF–GCSF treatment dramatically increased a cell population showing upregulation of marker genes related to peripheral myeloid cells. Flow cytometry data also revealed an SCF–GCSF–induced increase of cerebral CD45high–CD11b positive active phagocytes. SCF–GCSF treatment robustly increased the transcription of genes implicated in immune cell activation, including gene sets that regulate inflammatory processes and cell migration. Expression of S100a8 and S100a9 were robustly enhanced following SCF–GCSF treatment in all CD11b positive cell clusters. Moreover, the topmost genes differentially expressed with SCF–GCSF treatment were largely upregulated in S100a8–S100a9 positive cells, suggesting a well–conserved transcriptional profile related to SCF–GCSF treatment in resident and peripherally derived CD11b positive immune cells. This S100a8–S100a9–associated transcriptional profile contained notable genes related to proinflammatory and antiinflammatory responses, neuroprotection, and amyloid beta plaque inhibition or clearance. Altogether, this study reveals immunomodulatory effects of SCF–GCSF treatment in the aged brain with Alzheimers disease pathology, which will guide future studies to further uncover the therapeutic mechanisms.

CISD2 Attenuates Inflammation and Regulates Microglia Polarization in EOC Microglial Cells—As a Potential Therapeutic Target for Neurodegenerative Dementia

Anti-Inflammatory CDGSH Iron-Sulfur Domain 2: A Biomarker of Central Nervous System Insult in Cellular, Animal Models and Patients

Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-κB pathway in rats.

Icariside II Attenuates Lipopolysaccharide-Induced Neuroinflammation Through Inhibiting TLR4/MyD88/NF-κB Pathway in Rats

337 Cellular senescence contributes to inflammation and disease progression in an animal model of multiple sclerosis

Activation of CB2 Receptor System Restores Cognitive Capacity and Hippocampal Sox2 Expression in a Transgenic Mouse Model of Alzheimer's Disease

Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease

TREM2 and CD163 Ameliorate Microglia-Mediated Inflammatory Environment in the Aging Brain

Abstract 16: Inhibiting Ezh2 Is Neuroprotective After Stroke In Aged Mice

Upregulation of Neuronal Cylindromatosis Expression is Essential for Electroacupuncture-Mediated Alleviation of Neuroinflammatory Injury by Regulating Microglial Polarization in Rats Subjected to Focal Cerebral Ischemia/Reperfusion

Senolytic treatment depletes microglia and decreases severity of experimental autoimmune encephalomyelitis

Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy

Abstract P759: Microglial EZH2 Inhibition Leads to Neuroprotection After Stroke in Aged Mice

Cannabinoid type 2 receptor deficiency leads to Aβ-induced cognitive impairment through promoting microglial sensitivity to Aβ in the prefrontal cortex in mice

Transcription Factor Myocyte Enhancer Factor 2D Regulates Interleukin-10 Production in Microglia to Protect Neuronal Cells from Inflammation-Induced Death

The aging mouse CNS is protected by an autophagy-dependent microglia population promoted by IL-34

CDGSH iron sulfur domain 2 over-expression alleviates neuronal ferroptosis and brain injury by inhibiting lipid peroxidation via AKT/mTOR pathway following intracerebral hemorrhage in mice

CysLT 2 Receptor Mediates Lipopolysaccharide-Induced Microglial Inflammation and Consequent Neurotoxicity in Vitro

Single cell RNA sequencing reveals immunomodulatory effects of stem cell factor and granulocyte colony-stimulating factor treatment in the brains of aged APP/PS1 mice

Intestinal Epithelial Cell-Specific Deletion of Cytokine-Inducible SH2- Containing Protein Alleviates Experimental Colitis in Ageing Mice

JNK-mediated Microglial DICER Degradation Potentiates Inflammatory Responses to Induce Dopaminergic Neuron Loss